The Big Molecule Watch team looks forward to seeing you during the next couple of days at American Conference Institute’s 7th Annual Biosimilars Summit. Our colleague, Goodwin partner Sarah Frederick, will address how to distinguish a biosimilar product from the reference product while minimizing the risk of legal claims that may…
